PD1/PD-L1 targeting in ASPS: a pooled analysis of phase II trials
Posted: Mon Sep 07, 2020 11:26 pm
PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials
https://pubmed.ncbi.nlm.nih.gov/32430039/
Analysis by histological subtype revealed that patients with alveolar soft part sarcoma and undifferentiated pleomorphic sarcoma exhibited the highest response rates and leiomyosarcoma the lowest. PD-L1 expression rate was low and inconsistently associated with objective response.
https://pubmed.ncbi.nlm.nih.gov/32430039/
Analysis by histological subtype revealed that patients with alveolar soft part sarcoma and undifferentiated pleomorphic sarcoma exhibited the highest response rates and leiomyosarcoma the lowest. PD-L1 expression rate was low and inconsistently associated with objective response.